Baoweile (Guangzhou) Nutrition Technology Co., LTD – Trademark Portfolio
Entity Type: 99
Baoweile (Guangzhou) Nutrition Technology Co., LTD holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include GUMIETHF and TREASEALTH. The owner is based in Guangzhou.
Rm.716-3, 7F, No. 1498 Fanghua Rd.,
Renhe Vil., Renhe Town, Baiyun District,
Guangzhou 510000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Baoweile (Guangzhou) Nutrition Technology Co., LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Baoweile (Guangzhou) Nutrition Technology Co., LTD have?
Baoweile (Guangzhou) Nutrition Technology Co., LTD has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Baoweile (Guangzhou) Nutrition Technology Co., LTD file in?
Baoweile (Guangzhou) Nutrition Technology Co., LTD files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Baoweile (Guangzhou) Nutrition Technology Co., LTD's most well-known trademarks?
Baoweile (Guangzhou) Nutrition Technology Co., LTD's registered trademark portfolio includes well-known marks such as GUMIETHF and TREASEALTH. These are among 2 currently registered trademarks in the portfolio.
What is Baoweile (Guangzhou) Nutrition Technology Co., LTD's trademark registration success rate?
Baoweile (Guangzhou) Nutrition Technology Co., LTD has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.